PENG Xue-biao, CAI Yan-tao, WANG Na. Relationship between methylene tetrahydrofolate reductase gene polymorphism and systemic lupus erythematosus[J].Chinese Journal of Dermatology, 2007, 40(10): 612-614.
[1] Ward MM.Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus.Arthritis Rheum,1999,42(2):338-346. [2] Petri M,Roubenoff R,Dallal GE,et al.Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus.Lancet,1996,348(9035):1120-1124. [3] Kang SS,Zhou J,Wong PW,et al.Intermediate homocysteinemia:a thermolabile variant of methylenetetrahydrofolate reductase.Am J Hum Genet,1988,43(4):414-421. [4] Bombardier C,Gladman DD,Urowitz MB,et al.Derivation of the SLEDAI.A disease activity index for lupus patients.The Committee on Prognosis Studies in SLE.Arthritis Rheum,1992,35(6):630-640. [5] Von Feldt JM,Scalzi LV,Cucchiara AJ,et al.Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.Arthritis Rheum,2006,54(7):2220-2227. [6] Sanchez-Marin B,Grasa JM.Methylenetetrahydrofolate reductase(MTHFR) C677T polymorphism in ischemic vascular disease.Rev Neurol,2006,43(10):630-636.. [7] 满孝勇,李学平,郑经芬,等.系统红斑狼疮患者器官/系统损伤的评估.中华皮肤科杂志,2004,37(1):22-23.